The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next

Yonghee Song(Cell Biologics (United States)), Youngeun Kim(Cell Biologics (United States)), Sun‐Hyung Ha(Cell Biologics (United States)), Samantha Sheller‐Miller(The University of Texas Medical Branch at Galveston), Jae‐Kwang Yoo(Cell Biologics (United States)), Chulhee Choi(Korea Advanced Institute of Science and Technology), Cheol Hyoung Park(Cell Biologics (United States))
American Journal of Reproductive Immunology
September 2, 2020
Cited by 86Open Access
Full Text

Abstract

The extracellular vesicles (EVs) research area has grown rapidly because of their pivotal roles in intercellular communications and maintaining homeostasis of individual organism. As a subtype of EVs, exosomes are made via unique biogenesis pathway and exhibit disparate functional and phenotypic characteristics. Functionally, exosomes transfer biological messages from donor cell to recipient cell, which makes exosomes as a novel therapeutic platform delivering therapeutic materials to the target tissue/cell. Currently, both academia and industry try to develop exosome platform-based therapeutics for disease management, some of which are already in clinical trials. In this review, we will discuss focusing on therapeutic values of exosomes, recent advances in therapeutic exosome platform development, and late development of exosome therapeutics in diverse therapeutic areas.


Related Papers

No related papers found

Powered by citation graph analysis